An Immunothrombotic Extracellular Vesicle mRNA Profile Associated with Thrombosis in Lung Adenocarcinoma
Authors:
- María Marcos-JubilarMMMaría Marcos-Jubilar
- Clara Fernandez-AriasCFClara Fernandez-Arias
- Carmen Herrero-CarrascoCHCarmen Herrero-Carrasco
- Elizabeth GuruceagaEGElizabeth Guruceaga
- Karmele ValenciaKVKarmele Valencia
- Pablo ElizaldePEPablo Elizalde
- Susana InogesSISusana Inoges
- Ramón LecumberriRLRamón Lecumberri
- Josune OrbeJOJosune Orbe
Open Access
- 19 June 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (12) , 5558
Abstract
Venous thromboembolism (VTE) significantly impacts lung adenocarcinoma outcomes, yet current predictive tools lack precision. We investigated plasma extracellular vesicle (EV) mRNA as a liquid biopsy source to identify a pro-thrombotic molecular profile in VTE patients. Within a prospective cohort of 260 patients, we performed a retrospective nested case–control study, matching 10 VTE cases with 11 thrombosis-free controls. Plasma EV-RNA was analyzed via high-throughput sequencing. Differentially expressed genes (DEGs) were integrated with functional enrichment and explored across public non-cancer VTE datasets, buffy coat samples, and cell lines. RNA-seq identified 483 DEGs within the VTE patient EV compartment, predominantly linked to neutrophil degranulation (NETosis), inflammation, and coagulation. We identified a set of EV-associated candidate genes (SELP, ELANE, MYL9, DNASE1L3) distinguishing cancer-associated thrombosis from non-malignant VTE, along with transcripts (TFPI, FCGR2A) selectively enriched within the EV compartment relative to circulating blood cells. P-selectin (SELP) was the only significantly increased marker, providing the strongest complementary support at the protein level. This molecular state was detectable prior to the occurrence of VTE. Plasma EVs capture a multicellular mRNA profile, reflecting the systemic immunothrombotic activation in lung adenocarcinoma. Despite sample size limitations, these findings should be considered exploratory and hypothesis-generating, but they suggest the EV-derived mRNA in combination with circulating markers such as SELP may provide a framework for future studies aimed at improving risk stratification.Keywords
Funding Information
- Instituto de Salud Carlos III
- Instituto de Salud Carlos III (RD24/0009/0028)
This publication has 49 references indexed in Scilit:
- Cancer Cell‐Derived Large Extracellular Vesicles Promote Venous Thromboembolism by Activating NETosis Through Delivering CYBAAdvanced Science, 2025
- Cancer genetic profile and risk of thrombosisEuropean Journal of Internal Medicine, 2025
- Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2Cell, 2025
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activityJournal of Thrombosis and Haemostasis, 2024
- Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohortJournal of Thrombosis and Haemostasis, 2023
- Context-specific regulation of extracellular vesicle biogenesis and cargo selectionNature Reviews Molecular Cell Biology, 2023
- clusterProfiler 4.0: A universal enrichment tool for interpreting omics dataThe Innovation, 2021
- High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk scoreThrombosis Research, 2020
- Comparison of Pathogenic Mechanisms Underlying Single and Recurrent Venous Thromboembolism Based on Gene Expression ProfilingAnnals of Vascular Surgery, 2016